Powdery respiratory tonic composition
    6.
    发明申请
    Powdery respiratory tonic composition 审中-公开
    粉刺呼吸补品组成

    公开(公告)号:US20050163724A1

    公开(公告)日:2005-07-28

    申请号:US10514563

    申请日:2003-06-13

    摘要: The present invention relates to powdery inhalant compositions, each of which contains a steroidal anti-inflammatory drug, a carrier and water and has a water activity at 25° C. of from 0.35 to 0.75. Each powdery inhalant composition according to the present invention is high in the delivery rate of its steroidal anti-inflammatory drug to an inhalation target site from the nasal cavities or oral cavity, that is, to the alveoli, the bronchioles, the bronchial tubes or the airway, and allows the steroidal anti-inflammatory to exhibit its superb therapeutic effects.

    摘要翻译: 本发明涉及粉末吸入剂组合物,其各自含有甾族抗炎药物,载体和水,并且在25℃下具有0.35至0.75的水活性。 根据本发明的每种粉末吸入剂组合物,其甾族抗炎药物从鼻腔或口腔到吸入靶位点的递送速率高,即肺泡,细支气管,支气管或 气道,并且允许甾族抗炎剂表现出其极好的治疗效果。

    Compressed-molded preparations
    7.
    发明授权
    Compressed-molded preparations 失效
    压缩成型制剂

    公开(公告)号:US5275825A

    公开(公告)日:1994-01-04

    申请号:US757983

    申请日:1991-09-12

    IPC分类号: A61K9/20 A61K9/26 A61K9/16

    CPC分类号: A61K9/2081

    摘要: Compressed molded preparations are disclosed. In the preparation coated granules of a pharmaceutical composition are compressed and molded together with non-coated component(s) containing 10% or more by weight of non-swelling polymers. According to the preparation there is little breakdown of the coating of coated granules at the time of compressing and molding, and the rate of disintegration, and in turn, the release rate of the pharmaceutical component, can be freely controlled or modulated.

    摘要翻译: 公开了压缩成型制品。 在制备药物组合物的包衣颗粒中,与含有10重量%或更多重量的非溶胀聚合物的未涂覆组分一起压制和模塑。 根据制备,在压缩和模制时,涂层颗粒的涂层几乎没有破裂,并且可以自由地控制或调节崩解速率,进而释放出药物成分的释放速率。

    Meloxicam compositions
    8.
    发明申请
    Meloxicam compositions 审中-公开
    美洛昔康组合物

    公开(公告)号:US20050038018A1

    公开(公告)日:2005-02-17

    申请号:US10885260

    申请日:2004-07-06

    摘要: A pharmaceutical composition comprising: (a) meloxicam or a pharmaceutically acceptable salt thereof; and (b) one or more additional pharmaceutically active compounds selected from antacids, sedatives, and central nervous system stimulants, and the use of such composition of an inflammatory disease, symptoms of an inflammatory disease, including various symptoms thereof, and/or headache, toothache, ache after tooth extraction, sore throat, otalgia, arthralgia, neuralgia, lumbago, myalgia, muscle stiffness of shoulder, pain of contusion, pain of fracture, pain of sprain, menstrual pain, traumatic pain, chill, exothermic reaction and/or cold and various symptoms of cold such as sore throat, chill, pyrexia, headache, arthralgia and muscle pain.

    摘要翻译: 一种药物组合物,其包含:(a)美洛昔康或其药学上可接受的盐; 和(b)选自抗酸剂,镇静剂和中枢神经系统兴奋剂的一种或多种另外的药学活性化合物,以及使用这种炎性疾病组合物,炎性疾病症状,包括其各种症状和/或头痛, 牙痛,拔牙后疼痛,咽痛,关节痛,神经痛,腰痛,肌痛,肩部肌肉僵硬,挫伤疼痛,骨折疼痛,扭伤疼痛,月经痛,创伤性疼痛,寒战,放热反应和/或 寒冷多种症状,如喉咙痛,寒战,发热,头痛,关节痛和肌肉疼痛。